Potassium permanganate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Potassium permanganate
Accession Number
DB13831
Type
Small Molecule
Groups
Experimental, Investigational
Description
Not Available
Structure
Thumb
Synonyms
Not Available
External IDs
NSC-146182
Categories
UNII
00OT1QX5U4
CAS number
7722-64-7
Weight
Average: 158.032
Monoisotopic: 157.881409
Chemical Formula
KMnO4
InChI Key
VZJVWSHVAAUDKD-UHFFFAOYSA-N
InChI
InChI=1S/K.Mn.4O/q+1;;;;;-1
IUPAC Name
potassium manganesoylolate
SMILES
[K+].[O-][Mn](=O)(=O)=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic AcidThe risk or severity of hyperkalemia can be increased when Potassium permanganate is combined with 1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid.
AcebutololPotassium permanganate may increase the hyperkalemic activities of Acebutolol.
AceclofenacPotassium permanganate may increase the hyperkalemic activities of Aceclofenac.
AcemetacinPotassium permanganate may increase the hyperkalemic activities of Acemetacin.
Acetylsalicylic acidPotassium permanganate may increase the hyperkalemic activities of Acetylsalicylic acid.
AgmatinePotassium permanganate may increase the hyperkalemic activities of Agmatine.
AlclofenacPotassium permanganate may increase the hyperkalemic activities of Alclofenac.
AliskirenPotassium permanganate may increase the hyperkalemic activities of Aliskiren.
AlminoprofenPotassium permanganate may increase the hyperkalemic activities of Alminoprofen.
AlprenololPotassium permanganate may increase the hyperkalemic activities of Alprenolol.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Evidence Level

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
22810
ChEMBL
CHEMBL3833305
Wikipedia
Potassium_permanganate
ATC Codes
V03AB18 — Potassium permanganateD08AX06 — Potassium permanganate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedPreventionHealthcare-Associated Pneumonia / Hospital-acquired bacterial pneumonia / Pneumonia, Aspiration / Ventilator-Associated Pneumonia (VAP)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-2.3ChemAxon
pKa (Strongest Acidic)-7ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area74.27 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity5.77 m3·mol-1ChemAxon
Polarizability6.08 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Description
This compound belongs to the class of inorganic compounds known as alkali metal permanganates. These are inorganic compounds in which the largest oxoanion is permanganate, and in which the heaviest atom not in an oxoanion is an alkali metal.
Kingdom
Inorganic compounds
Super Class
Mixed metal/non-metal compounds
Class
Alkali metal oxoanionic compounds
Sub Class
Alkali metal permanganates
Direct Parent
Alkali metal permanganates
Alternative Parents
Inorganic salts / Inorganic oxides
Substituents
Alkali metal permanganate / Inorganic oxide / Inorganic salt
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on June 23, 2017 14:49 / Updated on November 02, 2018 07:46